Increased vitreous shedding of microparticles in proliferative diabetic retinopathy stimulates endothelial proliferation

Diabetes

Volumn 59, Issue 3, 2010, Pages 694-701

  Chahed, Sadri ^a,b   Leroyer, Aurélie S ^a   Benzerroug, Mounir ^a,c   Gaucher, David ^b   Georgescu, Adriana ^d   Picaud, Serge ^e   Silvestre, Jean Sébastien ^a   Gaudric, Alain ^b   Tedgui, Alain ^a   Massin, Pascale ^b   Boulanger, Chantal M ^a  

^a PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c ROUEN UNIVERSITY HOSPITAL   (France)

^d INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU   (Romania)

^e INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; INSULIN; COLLAGEN; LAMININ; MATRIGEL; PROTEOGLYCAN;

ADULT; ANGIOGENESIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE COURSE; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; MICROPARTICLE ENZYME IMMUNOASSAY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHOTORECEPTOR; PRIORITY JOURNAL; RETINA BLOOD VESSEL; VITREOUS BODY; AGED; ANIMAL; C57BL MOUSE; CELL DIVISION; DRUG COMBINATION; MICROGLIA; MIDDLE AGED; MOUSE; NEOVASCULARIZATION (PATHOLOGY); PARTICLE SIZE; PATHOLOGY; PHOTORECEPTOR CELL; PHYSIOLOGY; THROMBOCYTE; VITRECTOMY;

AGED; ANIMALS; BLOOD PLATELETS; CELL DIVISION; COLLAGEN; DIABETIC RETINOPATHY; DISEASE PROGRESSION; DRUG COMBINATIONS; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; LAMININ; LIGHT COAGULATION; MALE; MICE; MICE, INBRED C57BL; MICROGLIA; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PARTICLE SIZE; PHOTORECEPTOR CELLS, VERTEBRATE; PROTEOGLYCANS; RETINAL VESSELS; VITRECTOMY; VITREOUS BODY;

EID: 77950360653     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db08-1524     Document Type: Article

References (49)

1. Frank RN. Diabetic retinopathy. N Engl J Med 2004;350:48-58
2. Kern TS, Barber AJ. Retinal ganglion cells in diabetes. J Physiol 2008;586:4401-4408
3. Curtis TM, Gardiner TA, Stitt AW. Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis? Eye 2009;23:1496-1508
4. Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997;89:1121-1132
5. Boulanger CM, Scoazec A, Ebrahimian T, Henry P, Mathieu E, Tedgui A, Mallat Z. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 2001;104:2649-2652 (Pubitemid 33108128)
6. Nieuwland R, Berckmans RJ, Rotteveel-Eijkman RC, Maquelin KN, Roozendaal KJ, Jansen PG, Have K, Eijsman L, Hack CE, Sturk A. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation 1997;96:3534-3541
7. Barry OP, Pratico D, Savani RC, FitzGerald GA. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest 1998;102:136-144 (Pubitemid 28323840)
8. Brill A, Dashevsky O, Rivo J, Gozal Y, Varon D. Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization. Cardiovasc Res 2005;67:30-38 (Pubitemid 40798290)
9. Kim HK, Song KS, Chung JH, Lee KR, Lee SN. Platelet microparticles induce angiogenesis in vitro. Br J Haematol 2004;124:376-384
10. Boulanger CM, Tedgui A. Dying for attention: microparticles and angiogenesis. Cardiovasc Res 2005;67:1-3
11. Amabile N, Guerin AP, Leroyer A, Mallat Z, Nguyen C, Boddaert J, London GM, Tedgui A, Boulanger CM. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 2005;16:3381-3388
12. Agouni A, Lagrue-Lak-Hal AH, Ducluzeau PH, Mostefai HA, Draunet-Busson C, Leftheriotis G, Heymes C, Martinez MC, Andriantsitohaina R. Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. Am J Pathol 2008;173:1210-1219
13. Berckmans RJ, Nieuwland R, Tak PP, Boing AN, Romijn FP, Kraan MC, Breedveld FC, Hack CE, Sturk A. Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism. Arthritis Rheum 2002;46:2857-2866
14. Mallat Z, Hugel B, Ohan J, Leseche G, Freyssinet JM, Tedgui A. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 1999;99:348-353 (Pubitemid 29051259)
15. Boulanger CM, Amabile N, Tedgui A. Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. Hypertension 2006;48:180-186 (Pubitemid 44309805)
16. Hugel B, Martinez MC, Kunzelmann C, Freyssinet JM. Membrane microparticles: two sides of the coin. Physiology (Bethesda) 2005;20:22-27 (Pubitemid 40363367)
17. Diamant M, Nieuwland R, Pablo RF, Sturk A, Smit JW, Radder JK. Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus. Circulation 2002;106:2442-2447 (Pubitemid 35278799)
18. Sabatier F, Darmon P, Hugel B, Combes V, Sanmarco M, Velut JG, Arnoux D, Charpiot P, Freyssinet JM, Oliver C, Sampol J, Dignat-George F. Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. Diabetes 2002;51:2840-2845
19. Ogata N, Nomura S, Shouzu A, Imaizumi M, Arichi M, Matsumura M. Elevation of monocyte-derived microparticles in patients with diabetic retinopathy. Diabetes Res Clin Pract 2006;73:241-248 (Pubitemid 44107585)
20. Ogata N, Imaizumi M, Nomura S, Shozu A, Arichi M, Matsuoka M, Matsumura M. Increased levels of platelet-derived microparticles in patients with diabetic retinopathy. Diabetes Res Clin Pract 2005;68:193-201 (Pubitemid 40775985)
21. Mizutani M, Kern TS, Lorenzi M. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest 1996;97:2883-2890 (Pubitemid 26197103)
22. Barber AJ. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry 2003;27:283-290
23. Kerrigan LA, Zack DJ, Quigley HA, Smith SD, Pease ME. TUNEL-positive ganglion cells in human primary open-angle glaucoma. Arch Ophthalmol 1997;115:1031-1035 (Pubitemid 27328493)
24. Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, Janicki H, Schraermeyer U, Kociok N, Fauser S, Kirchhof B, Kern TS, Adamis AP. A central role for inflammation in the pathogenesis of diabetic retinopathy. Faseb J 2004;18:1450-1452 (Pubitemid 39561611)
25. Cho EY, Choi HL, Chan FL. Expression pattern of glycoconjugates in rat retina as analysed by lectin histochemistry. Histochem J 2002;34:589-600
26. Lunemann A, Ullrich O, Diestel A, Jons T, Ninnemann O, Kovac A, Pohl EE, Hass R, Nitsch R, Hendrix S. Macrophage/microglia activation factor expression is restricted to lesion-associated microglial cells after brain trauma. Glia 2006;53:412-419
27. Johnson LV, Hageman GS. Enzymatic characterization of peanut agglutinin-binding components in the retinal interphotoreceptor matrix. Exp Eye Res 1987;44:553-565
28. Thornton PD, Gerke MB, Plenderleith MB. Histochemical localisation of a galactose-containing glycoconjugate expressed by sensory neurones innervating different peripheral tissues in the rat. J Peripher Nerv Syst 2005;10:47-57
29. Blanks JC, Hageman GS, Johnson LV. Appearance of PNA-binding cells within the outer nuclear layer coinciding with photoreceptor degeneration in rd mice. Prog Clin Biol Res 1987;247:229-242
30. Passaniti A, Taylor RM, Pili R, Guo Y, Long PV, Haney JA, Pauly RR, Grant DS, Martin GR. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab Invest 1992;67:519-528
31. VanWijk MJ, VanBavel E, Sturk A, Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc Res 2003;59:277-287
32. Preston RA, Jy W, Jimenez JJ, Mauro LM, Horstman LL, Valle M, Aime G, Ahn YS. Effects of severe hypertension on endothelial and platelet microparticles. Hypertension 2003;41:211-217
33. Koga H, Sugiyama S, Kugiyama K, Fukushima H, Watanabe K, Sakamoto T, Yoshimura M, Jinnouchi H, Ogawa H. Elevated levels of remnant lipoproteins are associated with plasma platelet microparticles in patients with type-2 diabetes mellitus without obstructive coronary artery disease. Eur Heart J 2006;27:817-823
34. Taraboletti G, D'Ascenzo S, Borsotti P, Giavazzi R, Pavan A, Dolo V. Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am J Pathol 2002;160:673-680
35. Adamis AP. Is diabetic retinopathy an inflammatory disease? Br J Ophthalmol 2002;86:363-365
36. Witmer AN, Vrensen GF, Van Noorden CJ, Schlingemann RO. Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res 2003;22:1-29
37. Snead DR, Cullen N, James S, Poulson AV, Morris AH, Lukaris A, Scott JD, Richards AJ, Snead MP. Hyperconvolution of the inner limiting membrane in vitreomaculopathies. Graefes Arch Clin Exp Ophthalmol 2004;242:853-862
38. Photocoagulation treatment of proliferative diabetic retinopathy: the second report of diabetic retinopathy study findings. Ophthalmology 1978;85:82-106
39. Stefansson E. Ocular oxygenation and the treatment of diabetic retinopathy. Surv Ophthalmol 2006;51:364-380
40. Gariano RF, Gardner TW. Retinal angiogenesis in development and disease. Nature 2005;438:960-966
41. Diabetic Retinopathy Study Group. Photocoagulation treatment of proliferative diabetic retinopathy: the second report of diabetic retinopathy study findings. Ophthalmology 1978;85:82-106
42. Avery RL. Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment. Retina 2006;26:352-354
43. Spaide RF, Fisher YL. Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina 2006;26:275-278
44. Mason JO 3rd, Nixon PA, White MF. Intravitreal injection of bevacizumab (Avastin) as adjunctive treatment of proliferative diabetic retinopathy. Am J Ophthalmol 2006;142:685-688
45. Chen E, Park CH. Use of intravitreal bevacizumab as a preoperative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy. Retina 2006;26:699-700
46. Avery RL, Pearlman J, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ, Wendel R, Patel A. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 2006;113:1695.e1-1665.e15
47. Leroyer AS, Rautou PE, Silvestre JS, Castier Y, Leseche G, Devue C, Duriez M, Brandes RP, Lutgens E, Tedgui A, Boulanger CM. CD40 ligand+ microparticles from human atherosclerotic plaques stimulate endothelial proliferation and angiogenesis a potential mechanism for intraplaque neovascularization. J Am Coll Cardiol 2008;52:1302-1311
48. Mezentsev A, Merks RM, O'Riordan E, Chen J, Mendelev N, Goligorsky MS, Brodsky SV. Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress. Am J Physiol Heart Circ Physiol 2005;289:H1106-H1114
49. Yang C, Mwaikambo BR, Zhu T, Gagnon C, Lafleur J, Seshadri S, Lachapelle P, Lavoie JC, Chemtob S, Hardy P. Lymphocytic microparticles inhibit angiogenesis by stimulating oxidative stress and negatively regulating VEGF-induced pathways. Am J Physiol Regul Integr Comp Physiol 2008;294:R467-R476